Today's Date: February 1, 2023
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of National Vision Holdings, Inc. (EY   •   Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Fate Therapeutics, Inc. (FATE) Inv   •   THE RCMP, CAFC AND OPP RAISE AWARENESS AFTER AN INCREASE IN EMERGENCY - GRANDPARENT SCAMS   •   Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Avaya Holdings Corp (AVYA) Investo   •   Media Advisory: Military Veteran Receives Grant for Down Payment on First Home   •   Indianapolis-Based Marian University Selects YuJa Enterprise Video Platform to Serve as Video Content Creation and Management Sy   •   Aris Water Solutions, Inc. Provides Fourth Quarter 2022 Business Update and Announces Date and Time for Fourth Quarter and Full   •   Asian Pacific Islander American Scholars Welcomes Two New Members to the Board of Directors   •   Meijer Brings Midwest Artists' Works to Life in New Black History Month Collection Benefiting Urban Leagues   •   The Cowgirl Channel Set To Launch On DISH Network and SLING TV   •   dozanü innovations releases "The State of Accessible Marketing in 2023" report   •   Bumble Inc. To Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023   •   For A Bright Future Foundation Launches its Pioneering Media Lab Program at St. John Bosco High School in Los Angeles, Marking a   •   Climate action project in the District of Kitimat gets investment from Canada and British Columbia   •   Louis Bull Tribe and Canada sign historic agreement to further support the well-being of First Nations children and community   •   Castle Biosciences Earns a Top Workplaces USA Award for the Second Consecutive Year   •   Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Y-mAbs Therapeutics, Inc. (YMAB) I   •   Black History Month comes to life across SiriusXM Canada   •   Shareholder Alert: Robbins LLP Informs Investors of Class Action Against National Vision Holdings, Inc.   •   MGM RESORTS INTERNATIONAL HONORED AS A NATIONAL LEADER IN SUPPORTING WOMEN-OWNED BUSINESSES
Bookmark and Share

Kestra Medical Technologies Surpasses 100 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System

KIRKLAND, Wash. , November 29 /Businesswire/ - Kestra Medical Technologies announced today that the ASSURE® Wearable Cardioverter Defibrillator (WCD) system is now available in-network to over 100 million insurance plan members across the U.S. The company reached this covered-lives milestone for the ASSURE WCD system less than one year from when the first system entered service in late Fall 2021. The more than 100 million total covered lives includes broad coverage now in effect for members of federal, state, and national commercial insurers including UnitedHealthcare and multiple state Blue Cross Blue Shield (BCBS) plans, in addition to traditional Medicare and select state Medicaid coverage.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221129005625/en/

Kestra Medical Technologies announced today that the ASSURE® Wearable Cardioverter Defibrillator (WCD) system is now available as an in-network coverage benefit to over 100 million insurance plan members across the U.S. The ASSURE WCD system represents the next generation of monitoring and therapy to protect patients at risk of sudden cardiac arrest and has protected thousands of patients to date. (Photo credit: Kestra Medical Technologies, Inc.)

Kestra Medical Technologies announced today that the ASSURE® Wearable Cardioverter Defibrillator (WCD) system is now available as an in-network coverage benefit to over 100 million insurance plan members across the U.S. The ASSURE WCD system represents the next generation of monitoring and therapy to protect patients at risk of sudden cardiac arrest and has protected thousands of patients to date. (Photo credit: Kestra Medical Technologies, Inc.)

“As we continue our phased launch in select territories across the U.S., receiving these positive coverage decisions from multiple major insurers helps us rapidly advance our mission of protecting and supporting at-risk cardiac patients,” said Brian Webster, CEO of Kestra Medical Technologies. “It is clear that prescribers and payors alike are recognizing the benefit of an additional WCD option, especially with our focus on the underserved population of female cardiac patients.”

The ASSURE WCD system represents the next generation of monitoring and therapy to protect patients at risk of sudden cardiac arrest. The system includes a wearable device that provides autonomous detection and defibrillation for ventricular arrhythmias, when needed. It is the first WCD designed and developed with specific options for female cardiac patients. The complete Cardiac Recovery System® includes the ASSURE WCD, the ASSURE patient app, and Kestra CareStation™ remote patient data platform, all working together to provide comfortable protection for patients and clear insights for their healthcare providers.

Over the past year, patients ranging in age from 35 to 88 years old, presenting with a variety of cardiac risk factors and diagnoses, have had lethal cardiac arrythmias detected and lifesaving defibrillation delivered by an ASSURE WCD system. Thousands of patients have been prescribed—and protected by—an ASSURE WCD system since introduction.

About Kestra Medical Technologies

Kestra Medical Technologies, Inc. is a privately held wearable medical device and digital healthcare company that protects cardiac patients with diagnostic monitoring and therapeutic technologies that are intuitive, intelligent, and mobile. Kestra was founded in 2014 by leaders from the external (AED) and internal (ICD) defibrillation industries. Based in Kirkland, Washington, Kestra is a portfolio company of Bain Capital, one of the world’s leading alternative investment firms with deep global experience in healthcare. For more information, visit www.kestramedical.com.

Forward Looking Statements

Statements Kestra makes in this press release that relate to future plans, events, prospects, or performance are forward-looking statements and as such, are subject to a number of risks, uncertainties, assumptions, and other factors that could cause actual results to differ materially from the expectations expressed. While these current forward-looking statements represent the current beliefs of Management as of the date published, readers are cautioned not to place undue reliance on these forward-looking statements. Except as required by law, Kestra undertakes no obligation to update or revise any forward-looking statements to reflect new information, changed circumstances, or unanticipated events.


STORY TAGS: Photo/Multimedia, Washington, United States, North America, Women, Cardiology, Seniors, Insurance, Health, Medical Devices, Professional Services, Consumer, Product/Service,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News